Treatment of Rheumatoid Arthritis with Flurbiprofen or Ibuprofen
- 1 January 1977
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 17 (1) , 56-62
- https://doi.org/10.1002/j.1552-4604.1977.tb04586.x
Abstract
Flurbiprofen and ibuprofen were compared in a 6 wk double-blind randomized study in 208 patients with rheumatoid arthritis [RA]. Daily dosages were 120 mg flurbiprofen and 2400 mg ibuprofen for 6 wk. Both drugs were effective in providing partial control of RA symptoms. Either or both drugs produced statistically significant improvement in mean values of time of onset of fatigue, grip strength and tender and swollen joint counts. All other standard endpoints of efficacy (except ESR [erythrocyte sedimentation rate]) were improved but not at a statistically significant level. Slightly more than half of the patients improved during the trial. There was no statistically significant difference in the efficacy of the drugs. The incidence of side effects was low with both drugs. Most side effects were related to gastrointestinal tract irritation.This publication has 9 references indexed in Scilit:
- Ibuprofen or Aspirin in Rheumatoid Arthritis TherapyJAMA, 1975
- Effect of ibuprofen dosage on patient response in rheumatoid arthritisArthritis & Rheumatism, 1975
- A COMPARISON OF FLURBIPROFEN AND ASPIRIN IN THE TREATMENT OF RHEUMATOID ARTHRITISThe Medical Journal of Australia, 1974
- Double-blind Cross-over Trial of Flurbiprofen and Phenylbutazone in Ankylosing SpondylitisBMJ, 1974
- Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.Annals of the Rheumatic Diseases, 1974
- The pharmacology of 2-(2-fluoro-4-biphenylyl)Propionic acid (Flurbiprofen) A potent non-steroidal anti-inflammatory drugInflammation Research, 1973
- Proximal interphalangeal joint measurement by arthrocircameter.Annals of the Rheumatic Diseases, 1973
- Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent.Annals of the Rheumatic Diseases, 1972